LifeTech Scientific (FRA:81X) OCF Margin %: 22.80% (As of Dec. 2025) — 38% Below Median


FRA:81X LifeTech Scientific Corp FRA:81X
96 GF Score
Price €0.14
GF Value €0.21
! 4 Warning Signs
View Full Analysis

What is LifeTech Scientific OCF Margin %?

LifeTech Scientific FRA:81X -0.71% 96 OCF Margin % is 22.80% as of Dec. 2025, which is 38% below its 10-year median of 36.92. GuruFocus rates FRA:81X with a GF Score™ of 96/100 and a GF Value™ of €0.21. The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, LifeTech Scientific ranks better than 97.67% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. LifeTech Scientific's Cash Flow from Operations for the six months ended in Dec. 2025 was €19.2 Mil. LifeTech Scientific's Revenue for the six months ended in Dec. 2025 was €84.0 Mil. Therefore, LifeTech Scientific's OCF Margin % for the quarter that ended in Dec. 2025 was 22.80%.

As of today, LifeTech Scientific's current OCF Yield % is 9.99%.

The historical rank and industry rank for LifeTech Scientific's OCF Margin % or its related term are showing as below:

FRA:81X' s OCF Margin % Range Over the Past 10 Years
Min: 24.66   Med: 36.92   Max: 52.71
Current: 40.06


During the past 13 years, the highest OCF Margin % of LifeTech Scientific was 52.71%. The lowest was 24.66%. And the median was 36.92%.

FRA:81X's OCF Margin % is ranked better than
97.67% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 5.84 vs FRA:81X: 40.06


LifeTech Scientific OCF Margin % Related Terms


LifeTech Scientific OCF Margin % Historical Data

* Premium members only.

The historical data trend for LifeTech Scientific's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeTech Scientific OCF Margin % Chart

LifeTech Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.67 35.39 32.99 24.66 40.10

LifeTech Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.05 15.73 33.61 57.82 22.80

FRA:81X vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, LifeTech Scientific's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's OCF Margin % distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's OCF Margin % falls into.


FRA:81X
96GF Score
LifeTech Scientific Corp FRA:81X
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeTech Scientific OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

LifeTech Scientific's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=66.601/166.088
=40.10 %

LifeTech Scientific's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=19.159/84.036
=22.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 22.80% mean?
LifeTech Scientific (FRA:81X) has a OCF Margin % of 22.80% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LifeTech Scientific and its competitors. This is 38% below median its historical median of 36.92. Over the past decade, LifeTech Scientific's OCF Margin % has ranged from 24.66 to 52.71. According to the industry distribution chart, LifeTech Scientific ranks #19 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 2.3%.
Is LifeTech Scientific's OCF Margin % too high?
LifeTech Scientific's current OCF Margin % of 22.80% is 38% below median its 10-year median of 36.92. Over the past 10 years, this metric has ranged from a low of 24.66 to a high of 52.71. The Medical Devices & Instruments industry median OCF Margin % is 5.84. LifeTech Scientific's value of 22.80% is 290.4% above this industry median. Based on the distribution chart, LifeTech Scientific ranks #19 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #19 out of 816 companies for OCF Margin %. This places LifeTech Scientific in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.84. LifeTech Scientific's value of 22.80% is 290.4% above this benchmark. Historically, LifeTech Scientific's own OCF Margin % has ranged from 24.66 to 52.71 over the past decade. While the company's 10-year median is 36.92 vs. the industry median of 5.84, LifeTech Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current OCF Margin % of 22.80% is 290.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current OCF Margin % is 22.80%, which is 38% below median its own 10-year median of 36.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (FRA:81X) has a current OCF Margin % of 22.80%. The stock's GF Value™ is €0.21, compared to a current price of €0.14 — trading 33.3% below its estimated fair value. The current OCF Margin % is 22.80%, which is 38% below median its 10-year median of 36.92 and 290.4% above the Medical Devices & Instruments industry median of 5.84. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For LifeTech Scientific (FRA:81X), the current OCF Margin % is 22.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeTech Scientific (FRA:81X) Overvalued in 2026?

Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued. The current stock price of €0.14 is trading 33.3% below its estimated GF Value™ of €0.21.

Key valuation signals for FRA:81X:

  • OCF Margin %: 22.80% (38% below median its 10-year median of 36.92)
  • GF Value™: €0.21 vs. price of €0.14 (33.3% below fair value)
  • GF Score™: 96/100 with 4 warning signs
  • Industry Position: 290.4% above the Medical Devices & Instruments median (#19 of 816)

No single metric tells the full story. See the FRA:81X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LifeTech Scientific Business Description

Other Exchanges 01302:Hong Kong
Address No. 22, Keji 12th Road South, 14th Floor, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score

Get the complete analysis for FRA:81X

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.21
GF Value